Prevalence of extended-spectrum-β-lactamase-producing Escherichia coli from pigs at slaughter in the UK in 2013

被引:35
|
作者
Randall, L. P. [1 ]
Lemma, F. [1 ]
Rogers, J. P. [2 ]
Cheney, T. E. A. [1 ]
Powell, L. F. [1 ]
Teale, C. J. [3 ]
机构
[1] Anim Hlth & Vet Labs Agcy Weybridge, Addlestone KT15 3NB, Surrey, England
[2] Anim Hlth & Vet Labs Agcy Bury St Edmunds, Bury St Edmunds IP33 2BD, Suffolk, England
[3] Anim Hlth & Vet Labs Agcy Shrewsbury, Shrewsbury SY1 4HD, Salop, England
关键词
cephalosporins; resistance; CTX-M; SHV; ESBLs; CTX-M; FECAL CARRIAGE; ENTEROBACTERIACEAE; CHICKENS; TEM-52; CATTLE; FARMS; SWINE; ESBLS;
D O I
10.1093/jac/dku258
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To determine the prevalence and types of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli occurring in pigs at slaughter in the UK in 2013. Caecal samples from 637 pigs, sampled via a UK-wide monitoring programme in 2013, were enriched overnight in buffered peptone water, before plating to CHROMagar CTX and Oxoid Brilliance ESBL agar. Presumptive ESBL-producing E. coli from both media were tested for ESBL phenotype using MAST ES beta L ID discs. Isolates with an ESBL phenotype were examined for the presence of bla(CTX-M,) bla(OXA), bla(SHV) and bla(TEM) genes using a multiplex PCR. All bla(CTX-M) and bla(SHV) genes identified by PCR were sequenced. A total of 23.4% (95% CI 19.2-27.6) of pigs were positive for ESBL-producing E. coli; 22% (95% CI 17.8-26.1) of the pigs carried E. coli producing CTX-M enzymes [comprising enzyme types 1 (18.7% of pigs), 3 (0.2%), 14 (0.5%), 15 (1.4%), 27 (0.5%), 32 (0.5%) and 55 (0.3%)] and 2.2% (95% CI 0.8-3.6) of the pigs carried E. coli producing SHV-12. Five pigs carried both CTX-M- and SHV-12-producing E. coli as different isolates. There were no statistically significant differences observed between the two medium types in terms of the proportions of each CTX-M enzyme type isolated. In this UK study, 23.4% of pigs were found to be positive for ESBL-producing E. coli using selective culture media. The use of two different commercially available ESBL isolation media was found to improve the detection of ESBL-producing E. coli.
引用
收藏
页码:2947 / 2950
页数:4
相关论文
共 50 条
  • [21] A Probabilistic Transmission Model for the Spread of Extended-Spectrum-β-Lactamase and AmpC-β-Lactamase-Producing Escherichia Coli in the Broiler Production Chain
    Rodriguez, Carolina Plaza
    Carreira, Guido Correia
    Kaesbohrer, Annemarie
    RISK ANALYSIS, 2018, 38 (12) : 2659 - 2682
  • [22] Characterization of Fecal Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Remote Community during a Long Time Period
    Woerther, Paul-Louis
    Angebault, Cecile
    Jacquier, Herve
    Clermont, Olivier
    El Mniai, Assyia
    Moreau, Brigitte
    Djossou, Felix
    Peroz, Gilles
    Catzeflis, Francois
    Denamur, Erick
    Andremont, Antoine
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (10) : 5060 - 5066
  • [23] Prevalence and diversity of extended-spectrum-β-lactamase-producing Enterobacteriaceae from marine beach waters
    Maravic, Ana
    Skocibusic, Mirjana
    Cvjetan, Svjetlana
    Samanic, Ivica
    Fredotovic, Zeljana
    Puizina, Jasna
    MARINE POLLUTION BULLETIN, 2015, 90 (1-2) : 60 - 67
  • [24] Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia
    Matsumura, Yasufumi
    Yamamoto, Masaki
    Nagao, Miki
    Komori, Toshiaki
    Fujita, Naohisa
    Hayashi, Akihiko
    Shimizu, Tsunehiro
    Watanabe, Harumi
    Doi, Shoichi
    Tanaka, Michio
    Takakura, Shunji
    Ichiyama, Satoshi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) : 5107 - 5113
  • [25] Prevalence and Molecular Characterization of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in a Pediatric Patient Population
    Chandramohan, Lakshmi
    Revell, Paula A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4765 - 4770
  • [26] Susceptibility of extended-spectrum- -lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages
    Fitzgerald-Hughes, Deirdre
    Bolkvadze, Darajen
    Balarjishvili, Nana
    Leshkasheli, Lika
    Ryan, Maia
    Burke, Liam
    Stevens, Niall
    Humphreys, Hilary
    Kutateladze, Mzia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) : 1148 - 1150
  • [27] Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan
    Miyoshi-Akiyama, Tohru
    Sherchan, Jatan Bahadur
    Doi, Yohei
    Nagamatsu, Maki
    Sherchand, Jeevan B.
    Tandukar, Sarmila
    Ohmagari, Norio
    Kirikae, Teruo
    Ohara, Hiroshi
    Hayakawa, Kayoko
    MSPHERE, 2016, 1 (05)
  • [28] Is Fecal Carriage of Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Urban Rats a Risk for Public Health?
    Guenther, Sebastian
    Wuttke, Julia
    Bethe, Astrid
    Vojtech, Jiri
    Schaufler, Katharina
    Semmler, Torsten
    Ulrich, Rainer G.
    Wieler, Lothar H.
    Ewers, Christa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) : 2424 - 2425
  • [29] Reduction of extended-spectrum-β-lactamase- and AmpC-β-lactamase-producing Escherichia coli through processing in two broiler chicken slaughterhouses
    Pacholewicz, Ewa
    Liakopoulos, Apostolos
    Swart, Arno
    Gortemaker, Betty
    Dierikx, Cindy
    Havelaar, Arie
    Schmitt, Heike
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2015, 215 : 57 - 63
  • [30] Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Auer, Simon
    Wojna, Alexandra
    Hell, Markus
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 4006 - 4008